{"disease":{"id":"obstructive-pulmonary-disease","name":"obstructive pulmonary disease"},"drugs":{"marketed":[{"drug_id":"budesonide","indication_name":"Severe chronic obstructive pulmonary disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pulmicort Respules","generic_name":"BUDESONIDE","company_name":"AstraZeneca K.K.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":"2800","mechanism":""},{"drug_id":"tiotropium-bromide","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spiriva","generic_name":"TIOTROPIUM BROMIDE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic","quality_score":10,"revenue":"2500","mechanism":"Spiriva works by blocking the action of a chemical called acetylcholine, which causes airway muscles to contract and narrow the airways."},{"drug_id":"salbutamol","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Proventil","generic_name":"salbutamol","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"albuterol","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ProAir","generic_name":"albuterol","company_name":"Generic (originally Allen & Hanburys/GSK)","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-2 adrenergic receptor","drug_class":"SABA (Short-acting beta-2 agonist)","quality_score":56,"revenue":null,"mechanism":"Short-acting beta-2 adrenergic agonist (SABA) that relaxes bronchial smooth muscle, providing rapid relief of bronchospasm."},{"drug_id":"test-formulation-treatment-a","indication_name":"Acute Bacterial Exacerbation of Chronic Obstructive Pulmonary Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Test formulation (Treatment A)","generic_name":"test-formulation-treatment-a","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific enzyme","drug_class":"Enzyme inhibitor","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"atm-avi","indication_name":"Treatment of acute bacterial exacerbation of chronic obstructive pulmonary disease (ABECOPD) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"atm-avi","indication_name":"Treatment of acute bacterial exacerbation of chronic obstructive pulmonary disease (ABECOPD) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis in patients who have a penicillin tolerance test result of >= 20 mcg/mL.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."},{"drug_id":"ensifentrine","indication_name":"chronic obstructive pulmonary disease (COPD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ohtuvayre","generic_name":"ENSIFENTRINE","company_name":"Verona Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Phosphodiesterase 3 Inhibitor [EPC]","quality_score":47,"revenue":null,"mechanism":"Ohtuvayre works by blocking an enzyme called phosphodiesterase 3, which helps to increase the levels of a molecule called cyclic AMP in the lungs."},{"drug_id":"theophyllin","indication_name":"Asthma-chronic obstructive pulmonary disease overlap syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"carbocysteine","indication_name":"Reduction of sputum viscosity in chronic obstructive pulmonary disease (COPD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mucodyne","generic_name":"carbocysteine","company_name":"","drug_phase":"marketed","molecular_target":"Mucus glycoprotein synthesis","drug_class":"Mucolytic","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"ipratropium","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"ppsv23","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with chronic lung disease, including chronic obstructive pulmonary disease (COPD) and asthma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ppsv23","generic_name":"ppsv23","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"diprophylline","indication_name":"Asthma-chronic obstructive pulmonary disease overlap syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"terbutaline","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"daxas","indication_name":"Severe chronic obstructive pulmonary disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Daxas","company_name":"AstraZeneca","drug_phase":"phase_2","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B, cAMP-specific 3',5'-cyclic phosphodiesterase 4D","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Asthma-chronic obstructive pulmonary disease overlap syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Chronic Obstructive Pulmonary Disease with Bronchospasms","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"roflumilast","indication_name":"Severe chronic obstructive pulmonary disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Daliresp","generic_name":"ROFLUMILAST","company_name":"Arcutis","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4D","drug_class":"Phosphodiesterase 4 Inhibitor [EPC]","quality_score":63,"revenue":null,"mechanism":"Daliresp works by blocking an enzyme called phosphodiesterase 4, which helps reduce inflammation in the body."},{"drug_id":"formoterol","indication_name":"Severe chronic obstructive pulmonary disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Foradil","generic_name":"FORMOTEROL","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":56,"revenue":null,"mechanism":"Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."}],"pipeline":[{"drug_id":"scopolamine","indication_name":"Chronic obstructive pulmonary disease (COPD)","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SCOPOLAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptors","drug_class":"Anticholinergic [EPC]","quality_score":55,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":20,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT04206098","title":"Chart Review of Patients With COPD, Using Electronic Medical Records and Artificial Intelligence","phase":"","overall_status":"UNKNOWN","enrollment_count":2500000,"lead_sponsor_name":"Sociedad Española de Neumología y Cirugía Torácica","has_results":false},{"nct_id":"NCT05813652","title":"Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1","phase":"","overall_status":"COMPLETED","enrollment_count":919928,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05480176","title":"The China National COPD Screening Program","phase":"","overall_status":"UNKNOWN","enrollment_count":800000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT07416266","title":"Lower Respiratory Tract Infections Managed in Primary Care in France","phase":"","overall_status":"COMPLETED","enrollment_count":230066,"lead_sponsor_name":"Hôpital Raymond Poincaré","has_results":false},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT05457868","title":"Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists","phase":"","overall_status":"COMPLETED","enrollment_count":124117,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05179512","title":"Replication of the INSPIRE Trial in Healthcare Claims Data","phase":"","overall_status":"COMPLETED","enrollment_count":98278,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04966637","title":"Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data","phase":"","overall_status":"COMPLETED","enrollment_count":54028,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04684836","title":"Comparative Effectiveness of Telemedicine in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":33100,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":true},{"nct_id":"NCT07532564","title":"Risk Factors, Costs, and Impacts of ED Boarding","phase":"","overall_status":"COMPLETED","enrollment_count":30486,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT07332156","title":"Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas","phase":"","overall_status":"COMPLETED","enrollment_count":21692,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05497999","title":"Racial Inequality in Inhaler Fills for COPD - A Trial of Reduced Cost-Sharing","phase":"NA","overall_status":"COMPLETED","enrollment_count":19113,"lead_sponsor_name":"Harvard Medical School (HMS and HSDM)","has_results":false},{"nct_id":"NCT03945968","title":"The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.","phase":"","overall_status":"RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Russian Federation of Anesthesiologists and Reanimatologists","has_results":false},{"nct_id":"NCT05069194","title":"Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics","phase":"","overall_status":"UNKNOWN","enrollment_count":13000,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT02760329","title":"Observational Study of Obstructive Lung Disease (NOVELTY)","phase":"","overall_status":"COMPLETED","enrollment_count":12255,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03365713","title":"GECo: Implementation and Effectiveness of COPD Case-Finding in Low and Middle Income Countries","phase":"","overall_status":"COMPLETED","enrollment_count":10709,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06685315","title":"Research on the Characteristics of Chronic Airway Diseases (asthma, COPD)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10545,"lead_sponsor_name":"Henan University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT03359122","title":"Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients","phase":"","overall_status":"COMPLETED","enrollment_count":10067,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07382986","title":"IMPACT COPD Cohort (China)","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT03893409","title":"GIRH Chronic Obstructive Pulmonary Disease Observational Study","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"zili zhang","has_results":false},{"nct_id":"NCT05952999","title":"Analysis of the Virtual Acute Care at Home Experience","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":9654,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT05083429","title":"Replication of the POET-COPD Trial in Healthcare Claims Data","phase":"","overall_status":"COMPLETED","enrollment_count":8716,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06523257","title":"Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":8589,"lead_sponsor_name":"Sociedade Portuguesa de Pneumologia","has_results":false},{"nct_id":"NCT06456996","title":"Impact of Multi-Component Interventions on High Risk COPD Population","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7400,"lead_sponsor_name":"Peking Union Medical College","has_results":false},{"nct_id":"NCT05766046","title":"Lung Cancer Prevention Screening Programme in Italy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7324,"lead_sponsor_name":"Ugo Pastorino","has_results":false},{"nct_id":"NCT06573580","title":"Primary Health Management for Chronic Obstructive Pulmonary Disease","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT04048954","title":"Use of a Smartphone Application on the Detection of Complications Related to Smoking","phase":"","overall_status":"COMPLETED","enrollment_count":5671,"lead_sponsor_name":"Weprom","has_results":false},{"nct_id":"NCT03633838","title":"Clinical Outcome of Corticosteroids in the Treatment of COPD Exacerbations in China","phase":"","overall_status":"COMPLETED","enrollment_count":5067,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03131362","title":"Realize the Current Situation of COPD Patients in China","phase":"","overall_status":"COMPLETED","enrollment_count":5020,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04375280","title":"Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"University Hospital, Clermont-Ferrand","has_results":false},{"nct_id":"NCT06283966","title":"A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03207776","title":"An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":4832,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT04636801","title":"A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":4710,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":false},{"nct_id":"NCT03581227","title":"The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)","phase":"","overall_status":"COMPLETED","enrollment_count":4679,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT05690009","title":"Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":4580,"lead_sponsor_name":"Eurasian Association of Therapists","has_results":false},{"nct_id":"NCT04285047","title":"Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD)","phase":"","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Optimum Patient Care","has_results":false},{"nct_id":"NCT06316544","title":"China Elderly Comorbidity Medical Database","phase":"","overall_status":"UNKNOWN","enrollment_count":4100,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT07363980","title":"Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Ellen Margrethe Hauge","has_results":false},{"nct_id":"NCT06456749","title":"Xishui Project for IDM of COPD and Comorbidities","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4000,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03694431","title":"Comparative Trial of Home-Based Palliative Care","phase":"NA","overall_status":"TERMINATED","enrollment_count":3999,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT04636814","title":"A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":3973,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":false},{"nct_id":"NCT02552160","title":"DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":3732,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01966107","title":"Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":3635,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07414134","title":"Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation","phase":"","overall_status":"COMPLETED","enrollment_count":3598,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04536402","title":"Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":3520,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04664491","title":"Effects of COPD Standardized Management on COPD Exacerbation","phase":"NA","overall_status":"RECRUITING","enrollment_count":3456,"lead_sponsor_name":"China-Japan Friendship Hospital","has_results":false},{"nct_id":"NCT03425760","title":"A Cross-sectional Study of COPD and Symptom Variability in MEA Countries","phase":"","overall_status":"COMPLETED","enrollment_count":3254,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03046199","title":"Detection of COPD in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":3162,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT07457073","title":"AI-Powered Sound Analysis for COPD Screening","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Sir Run Run Shaw Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}